| |
| |
| Subcutaneous |
| CHRONIC MYELOID LEUKAEMIA |
| Adult:
4-5 million units/m2 daily; continue at the max tolerated dose to maintain remission. |
| Max Dosage: 4-10 million units/m2 daily. |
| |
| Subcutaneous |
| FOLLICULAR LYMPHOMA |
| Adult:
As an adjunct to chemotherapy: 5 million units 3 times wkly for 18 mth. |
| |
| Subcutaneous |
| CARCINOID TUMOURS |
| Adult:
3-9 million units (usually 5 million units) 3 times wkly. Advanced disease: 5 million units daily. |
| |
| Subcutaneous |
| MULTIPLE MYELOMA |
| Adult:
Maintenance dose following chemotherapy induction: 3 million units/m2 3 times wkly. |
| |
| Parenteral |
| CHRONIC ACTIVE HEPATITIS B |
| Adult:
5-10 million units IM/SC 3 times wkly for 4-6 mth, or 5 million units daily for 16 wk. |
| |
| Parenteral |
| CHRONIC HEPATITIS C |
| Adult:
3 million units IM/SC 3 times wkly for 6-12 mth (depending on genotype) when used with ribavirin, or for 6-18 mth (up to 24 mth) when used as monotherapy. |
| |
| Parenteral |
| AIDS-RELATED KAPOSI'S SARCOMA |
| Adult:
30 million units/m2 IM/SC 3 times wkly. |
| |
| Parenteral |
| HAIRY-CELL LEUKAEMIA |
| Adult:
2 million units/m2 IM/SC 3 times wkly for up to 6 mth or more. |
| |
| Parenteral |
| MELANOMA |
| Adult:
Initially, 20 million units/m2 daily for 5 days each wk for 4 wk by IV |
| |
| Injection |
| CONDYLOMATA ACUMINATA |
| Adult:
Inject 1 million units into each lesion 3 times wkly for 3 wk; repeat after 12-16 wk as needed. Max: 5 lesions per treatment course. |
